Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Dicerna Pharmaceuticals, Inc. (DRNA)

« Back to company index

DRNA Chatter Timeline

Stock Ticker for DRNA

Most Active Tweeters for DRNA

UserTweets
@AmericanBanking 7
@TickerReport 5
@TekATL3 4
@IRAMarketReport 3
@ZolmaxNews 3

Recent Tweets for DRNA

mikegoodma @mikegoodma
$DRNA gets BTD for PH1. FDA adds that PH2 + PH3 meet its criteria for BTD, and DRNA will continue discussions w FDA… https://t.co/fYHGlzV4AU
July 15th 2019, 2:07pm
portefeuillefun @portefeuillefun
RT @RNAiAnalyst: $DRNA Breakthrough Therapy Designation for DCR-PHXC for type 1 primary hyperoxaluria (but not types II+III): https://t.co/…
July 15th 2019, 12:07pm
MarketCurrents @MarketCurrents
$DRNA - Dicerna's DCR-PHXC a Breakthrough Therapy for rare kidney disorder https://t.co/qz9Bj1PsDs
July 15th 2019, 12:07pm
AmericanBanking @AmericanBanking
Dicerna Pharmaceuticals $DRNA Rating Reiterated by HC Wainwright https://t.co/GMoHkPaxpO #stocks
July 15th 2019, 11:07am
AlertTrade @AlertTrade
RT @Briefingcom: $DRNA: Dicerna Pharmaceuticals: FDA has granted a Breakthrough Therapy Designation to DCR-PHXC for the treatment of... htt…
July 15th 2019, 9:07am
Briefingcom @Briefingcom
$DRNA: Dicerna Pharmaceuticals: FDA has granted a Breakthrough Therapy Designation to DCR-PHXC for the treatment of… https://t.co/zdluJqzSK5
July 15th 2019, 9:07am
biostockinfo @biostockinfo
RT @BioBreakout: $DRNA Dicerna Pharma Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of PH1
July 15th 2019, 8:07am
InsiderBiotech @InsiderBiotech
$DRNA Dicerna Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of Primary Hyperoxaluria Type 1
July 15th 2019, 7:07am
RNAiAnalyst @RNAiAnalyst
$DRNA Breakthrough Therapy Designation for DCR-PHXC for type 1 primary hyperoxaluria (but not types II+III): https://t.co/Pd3Jae3LDy $ALNY
July 15th 2019, 7:07am
NewsToDesk @NewsToDesk
$DRNA: Dicerna Receives Breakthrough Therapy Designation for DCR …: https://t.co/VphDDnsQkB
July 15th 2019, 7:07am
ToothFrank @ToothFrank
$DRNA Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of Primary Hyperoxaluria Type 1 (PH1)
July 15th 2019, 7:07am
BioBreakout @BioBreakout
$DRNA Dicerna Pharma Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of PH1
July 15th 2019, 7:07am
TekATL3 @TekATL3
$DRNA breakthrough designation news
July 15th 2019, 7:07am
TraderTexMex @TraderTexMex
RT @BioStocks: $DRNA Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of Primary Hyperoxaluria Type 1 (PH1)
July 15th 2019, 7:07am
TekATL3 @TekATL3
$DRNA got to 16.90, like the longer term chart https://t.co/LHOtzBBqm3
July 14th 2019, 3:07pm
bbnsnews @bbnsnews
Head to Head Analysis: Horizon Therapeutics $HZNP versus Dicerna Pharmaceuticals $DRNA https://t.co/fVGSJ6RqCb
July 14th 2019, 5:07am
ThisLincolnian @ThisLincolnian
Head to Head Analysis: Horizon Therapeutics $HZNP versus Dicerna Pharmaceuticals $DRNA https://t.co/5mLHku1yw6
July 14th 2019, 5:07am
dakotafinancial @dakotafinancial
Brokerages Expect Dicerna Pharmaceuticals Inc $DRNA Will Post Quarterly Sales of $10.95 Million https://t.co/GVRnDA3v0Z
July 13th 2019, 6:07pm
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $DRNA https://t.co/jTa5imTE13
July 13th 2019, 10:07am
Gambiste1 @Gambiste1
RT @TradeFlags: TD BUY $DRNA at 14.20, Supp 14.20 Resis 15.83 R11 HiLo 56% T1Y 22 buy 1.7 fwdPE -10.2 DIV N/A #Dicerna Ph #stocks #trading…
July 13th 2019, 2:07am
TradeFlags @TradeFlags
TD BUY $DRNA at 14.20, Supp 14.20 Resis 15.83 R11 HiLo 56% T1Y 22 buy 1.7 fwdPE -10.2 DIV N/A #Dicerna Ph #stocks… https://t.co/9Wa7Dk8Ykr
July 13th 2019, 12:07am
xiscan1 @xiscan1
RT @SeekingAlpha: $DRNA - Dicerna: An RNA Therapy-Based 21st Century Likely Winner https://t.co/KE9Ra2KjwB
July 12th 2019, 1:07am
SeekingAlpha @SeekingAlpha
$DRNA - Dicerna: An RNA Therapy-Based 21st Century Likely Winner https://t.co/KE9Ra2KjwB
July 12th 2019, 1:07am
TickerReport @TickerReport
$10.95 Million in Sales Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/bemMsYN6H1
July 11th 2019, 11:07am
TickerReport @TickerReport
Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Earnings of -$0.32 Per Share https://t.co/VttO7ObMNd
July 11th 2019, 11:07am
ZolmaxNews @ZolmaxNews
Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Earnings of -$0.32 Per Share https://t.co/Nn4DARrRYv
July 11th 2019, 11:07am
TekATL3 @TekATL3
$DRNA possible pullback to 12.60ish area.
July 10th 2019, 7:07pm
ChartMill @ChartMill
$DRNA has an excellent technical rating and also presents a decent setup pattern. https://t.co/FeWeCr9eKr https://t.co/GDCJKAsATT
July 10th 2019, 6:07pm
IRAMarketReport @IRAMarketReport
Analysts Anticipate Dicerna Pharmaceuticals Inc $DRNA Will Post Earnings of -$0.32 Per Share https://t.co/ie67sk6HpK #markets
July 9th 2019, 10:07am
chaffeybreeze @chaffeybreeze
Analysts Anticipate Dicerna Pharmaceuticals Inc $DRNA Will Post Earnings of -$0.32 Per Share https://t.co/TOhuonj63X #stocks
July 9th 2019, 10:07am
WatchlistN @WatchlistN
Dicerna Pharmaceuticals $DRNA Cut to “Hold” at BidaskClub https://t.co/TzygTYbL8Y
July 7th 2019, 2:07am
AmericanBanking @AmericanBanking
Reviewing Horizon Therapeutics $HZNP and Dicerna Pharmaceuticals $DRNA https://t.co/r2StZnttjw #stocks
July 7th 2019, 2:07am
TickerReport @TickerReport
B. Riley Analysts Give Dicerna Pharmaceuticals $DRNA a $24.00 Price Target https://t.co/oiYR6vCYte
July 7th 2019, 2:07am
bbnsnews @bbnsnews
Citigroup Boosts Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/EM90RwNbeT
July 7th 2019, 1:07am
midetimes @midetimes
Citigroup Raises Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/p3TUC9xwMt #stocks
July 6th 2019, 7:07am
dailymailtimes @dailymailtimes
Citigroup Raises Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/xLFkn8kwIs #investing
July 6th 2019, 7:07am
dailypoliticaln @dailypoliticaln
Citigroup Raises Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/xdNYjwD1rn
July 6th 2019, 7:07am
ConsumerFeed @ConsumerFeed
Citigroup Raises Dicerna Pharmaceuticals $DRNA Price Target to $30.00 https://t.co/eGOuLtsY9y
July 6th 2019, 7:07am
ConsumerFeed @ConsumerFeed
Dicerna Pharmaceuticals $DRNA Cut to Hold at BidaskClub https://t.co/RjO0394t3Y
July 6th 2019, 7:07am
IRAMarketReport @IRAMarketReport
Dicerna Pharmaceuticals $DRNA Cut to Hold at BidaskClub https://t.co/DEoLQcVizb #markets
July 6th 2019, 7:07am
chaffeybreeze @chaffeybreeze
Dicerna Pharmaceuticals $DRNA Cut to Hold at BidaskClub https://t.co/obJeBKaTgm #stocks
July 6th 2019, 7:07am
macondailynews @macondailynews
Dicerna Pharmaceuticals $DRNA Rating Reiterated by Cowen https://t.co/DhoDTfg2Ij
July 6th 2019, 4:07am
AmericanBanking @AmericanBanking
$10.95 Million in Sales Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/b8esOAjIM2 #stocks
July 6th 2019, 1:07am
WatchlistN @WatchlistN
Dicerna Pharmaceuticals $DRNA PT Set at $24.00 by B. Riley https://t.co/szOhGmAEXQ
July 5th 2019, 8:07pm
ZolmaxNews @ZolmaxNews
Dicerna Pharmaceuticals $DRNA PT Set at $24.00 by B. Riley https://t.co/2pC6LQzMDd
July 5th 2019, 8:07pm
midetimes @midetimes
Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target at B. Riley https://t.co/NZ7LnPuTGA #stocks
July 5th 2019, 8:07pm
dailymailtimes @dailymailtimes
Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target at B. Riley https://t.co/QWnJzl1732 #investing
July 5th 2019, 8:07pm
dailypoliticaln @dailypoliticaln
Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target at B. Riley https://t.co/iOPcJgSwmZ
July 5th 2019, 8:07pm
ThisLincolnian @ThisLincolnian
Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target by B. Riley Analysts https://t.co/fTwcHYF6iM
July 5th 2019, 8:07pm
OlympiaReport @OlympiaReport
Dicerna Pharmaceuticals $DRNA Given a $24.00 Price Target by B. Riley Analysts https://t.co/jh5BLDWwyY
July 5th 2019, 8:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.